[1]
Aldridge, S.J. et al. 2024. The (dis)continuing of antithrombotic drugs and its implications for occurrence of adverse cardiovascular and bleeding events in cancer patients during end of life. International Journal of Population Data Science. 9, 5 (Sept. 2024). DOI:https://doi.org/10.23889/ijpds.v9i5.2826.